QUOTE AND NEWS
StreetInsider.com  May 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/EntreMed%2C+Inc.+New+%28ENMD%29+Narrows+Q1+Loss/8339331.html for the full story.
Benzinga  May 6  Comment 
EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual Property Office of Patent Certificate No. ZL...
Benzinga  Apr 5  Comment 
EntreMed, Inc. (NASDAQ: ENMD) announced today that its Board of Directors has appointed two new individuals as directors.  Joining the Board are James Huang and Y. Alexander Wu, Ph.D. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO...
StreetInsider.com  Mar 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/EntreMed%2C+Inc.+New+%28ENMD%29+Swings+to+Q4+Loss/8202499.html for the full story.
Benzinga  Jan 24  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: EntreMed Shares of EntreMed (NASDAQ: ENMD), the Rockville, MD clinical-stage pharmaceutical company, rose 15% Wednesday on 5 times average...
Benzinga  Jan 23  Comment 
EntreMed (NASDSQ: ENMD) announced today the initiation of a single-center Phase 2 study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Advanced/Metastatic Soft Tissue Sarcoma" at Princess Margaret Hospital where the...
Benzinga  Jan 8  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: EntreMed Shares of EntreMed (NASDAQ: ENMD), the Rockville, MD clinical-stage pharmaceutical company, rose 26% Monday on 6 times average...
Benzinga  Jan 7  Comment 
EntreMed (NASDAQ: ENMD) announced today that EntreMed has submitted a new drug clinical trial application with China's State Food and Drug Administration (SFDA) for its proprietary drug candidate, ENMD-2076, to conduct global clinical trials in...
Benzinga  Jan 4  Comment 
EntreMed (NASDAQ: ENMD) announced today the initiation of a second site for its Phase 2 study of ENMD-2076 in triple-negative breast cancer (TNBC).  Kathy Miller, MD, Associate Professor at the Melvin and Bren Simon Cancer Center at Indiana...
StreetInsider.com  Nov 26  Comment 
China BAK Battery, Inc. (Nasdaq: CBAK) 72.7% HIGHER; making a strong move back above the key $2 level on tremendous volume today. EntreMed, Inc. (Nasdaq: ENMD) 29.4% HIGHER; announced the publication of favorable results of a preclinical study in...




 





References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki